Medigen Vaccine Biologics Corporation (6547)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
52. 00
+0.1
+0.1927%
NT$
- Market Cap
- P/E Ratio
40% Div Yield
2.05M Volume
- Eps
NT$ 51.9
Previous Close Want to track 6547 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Medigen Vaccine Biologics Corporation (6547) Statistics
Valuation metrics
Market Cap -
Enterprise value 17.67B
Trailing P/E (ttm) -58.64
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) 28.1
Price/Book (mrq) 4.62
Enterprise Value/Revenue 29.27
Enterprise Value/EBITDA -132.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.84M
Average volume (90 days) 2.26M
Price summary
52-Week low 33.5
52-Week high 61.2
Beta -
50-Day moving average 46.87
200-Day moving average 45.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Jun 2026
Ex-Dividend Date 29 Jun 2026
Last split factor 1,482:1,000
Last split Date 3 Aug 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.48%
Operating margin -0.44%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.92
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.89
Total debt (mrq) -
Total Debt/Equity (mrq) 0.31
Current ratio (mrq) 15.32%
Book value per share (mrq) 11.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
